LYSA is an international association for clinical research against lymphoma, 6th most frequent cancer in Europe.
LYSA is labelled Cooperating Group by the French National Institute of Cancer (INCa), and has signed the independence chart of the Groupes Coopérateurs en Oncologie (GCO)
LYSA gathers french and belgium care centers around lymphoma patients care, from diagnostic to patient follow-up.
The LYSA group has been leading projects since first human administration of new treatments to new reference strategy therapies. LYSA collaborates with many scientific teams in order to understand and treat lymphomas. With its clinical research structure and biology, imaging and patholy platforms, LYSA proposes a complete expertise.